ENXTPA:SANPharmaceuticals
How Investors May Respond To Sanofi (ENXTPA:SAN) New Flu Vaccine Plant
Sanofi has opened the Charles Best Building in Toronto, a C$925 million flu vaccine facility that will produce Fluzone High-Dose for older adults and expand end to end manufacturing capacity in Canada, alongside a planned transfer of 20 mature medicines and three plants to Cheplapharm.
The combination of a large-scale Canadian vaccine build-out and a shift of mature products and sites to Cheplapharm highlights Sanofi’s push to concentrate internal resources on higher value R&D and biologics,...